SCHEMBL687544

SCHEMBL687544

CCOc1cccc(Cl)c1Cn1c(C)c(CC)c(O)c(NC(=O)N[C@@H](CC(=O)O)c2ccccc2)c1=O

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.38
CYP3A4 P08684 2/20 0.38
GNRHR P30968 1/20 0.38
MAPK1 P28482 1/20 0.37
NPSR1 Q6W5P4 2/20 0.35
RXFP1 Q9HBX9 1/20 0.35
POLB P06746 2/20 0.35
ALDH1A1 P00352 1/20 0.35
CTSA P10619 3/20 0.34
HTR1D P28221 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
TAS1R3 Q7RTX0 1/20 0.34
TAS1R1 Q7RTX1 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL688193 0.95 CTSA (0.39) SMN1; SMN2CYP3A4GNRHRNPSR1RXFP1
SCHEMBL688875 0.95 SMN1; SMN2 (0.37) SMN1; SMN2CYP3A4GNRHRMAPK1NPSR1
SCHEMBL688543 0.94 SMN1; SMN2 (0.38) SMN1; SMN2CYP3A4GNRHRMAPK1NPSR1
SCHEMBL687921 0.93 KMT2A (0.36) SMN1; SMN2CYP3A4GNRHRCYP2C9CYP2C19
SCHEMBL687048 0.89 CTSA (0.41) SMN1; SMN2CYP3A4GNRHRNPSR1RXFP1
SCHEMBL686800 0.88 PPARG (0.41) SMN1; SMN2CYP3A4GNRHRNPSR1RXFP1
SCHEMBL686719 0.87 MEN1 (0.38) SMN1; SMN2CYP3A4GNRHRMAPK1NPSR1
SCHEMBL27741949 0.87 PPARG (0.38) SMN1; SMN2
SCHEMBL686965 0.86 PPARG (0.40) SMN1; SMN2CYP3A4GNRHRKMT2A
SCHEMBL687480 0.84 CTSA (0.36) SMN1; SMN2ALDH1A1CTSAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203766-B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC (US) 2012-02-29 EP disclosed
EP-1203766-A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors TEXAS BIOTECHNOLOGY CORPORATION (US) 2002-05-08 EP disclosed